EU drug committee backs Eli Lilly's GLP-1 pill for obesity and type 2 diabetes
The EMA's CHMP issued a positive opinion on Friday recommending marketing authorization, a key step before a final European Commission decision on the oral drug.
Recap by typeshit. Full story at Benzinga on MSN.